- Report
- October 2024
- 201 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- October 2024
- 181 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- March 2025
- 400 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- March 2025
- 250 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- November 2024
- 120 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- July 2024
- 145 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- August 2024
- 138 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- March 2025
- 179 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 245 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 604 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- May 2024
- 327 Pages
Global
From €2662EUR$2,800USD£2,236GBP
€3803EUR$4,000USD£3,195GBP
- Report
- February 2025
- 182 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- February 2025
- 182 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- February 2025
- 182 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- February 2025
- 182 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- January 2025
- 182 Pages
Global
From €4278EUR$4,500USD£3,594GBP

Blood Plasma is a vital component of the pharmaceutical industry, used in the production of a variety of drugs and treatments. It is a component of the human body that is collected from healthy donors and used to create a range of products, including immunoglobulins, albumin, clotting factors, and other proteins. Plasma is also used to manufacture a variety of vaccines, including those for influenza, hepatitis, and rabies.
The demand for blood plasma has grown in recent years due to the increasing prevalence of chronic diseases and the need for more effective treatments. As a result, the market for blood plasma has become increasingly competitive, with a number of companies vying for a share of the market.
Some of the major players in the blood plasma market include CSL Behring, Grifols, Octapharma, Kedrion, and Biotest. These companies are involved in the collection, processing, and distribution of blood plasma products, as well as the development of new treatments and therapies. Show Less Read more